Clinical Trial Update: Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of Tamibarotene (OAM80) for Alzheimer's disease; this update summarizes the ongoing results and status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Tamibarotene (OAM80) (tamibarotene)

Snippet

Sponsor: Osaka City University | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN